Question

What is the recovery time after stem cell therapy for Chronic Wounds & Ulcers?

Recovery depends on the wound, perfusion, infection, product and route, so a universal clinic time or healing timeline is unsafe. Trial documents should describe administration, local and systemic adverse-event monitoring, urgent escalation and follow-up. Pressure relief, glucose control, vascular assessment, infection treatment and appropriate dressings must continue throughout.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Chronic Wounds & Ulcers

Chronic-wound studies of cells and extracellular vesicles vary by wound cause, vascular status, infection, product, delivery, comparator and definition of closure. Treated-cohort percentages and historical controls cannot establish comparative efficacy. Wound-area reduction is not equivalent to durable complete closure, limb salvage or fewer infections. No pooled response rate is published here because the studies are too heterogeneous for a single figure to be meaningful. The registered studies and their own prespecified endpoints are listed in the registry table on this page.

Am I a candidate? → · Chronic Wounds & Ulcers: full overview → · Chronic Wounds & Ulcers cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information